GlassScriptPhysician profile
Lorelei Ortega Diaz
NPI 1497380448
$1,453.62
in general payments reported to CMS, 2019-2025
9 companies · $760 in 2025
The $760 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.46 · 2023: $19.41 · 2024: $659 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $409.88 | 2024-2025 | Acthar |
| Alcon Vision LLC | $397.59 | 2024-2025 | Tryptyr, Hydrus Microstent, Voyager Dslt |
| Abbvie INC. | $233.26 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $148.16 | 2024-2025 | Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $105.40 | 2024 | |
| Apellis Pharmaceuticals, INC. | $94.00 | 2024 | Syfovre |
| Harrow Eye, LLC | $30.46 | 2025 | Vevye |
| Merck Sharp & Dohme LLC | $19.41 | 2023 | Vaxelis, Gardasil 9, Vaqta |
| Phadia US INC. | $15.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorelei Ortega Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.